These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275 [TBL] [Abstract][Full Text] [Related]
25. Antagonistic actions of S-145 on vascular and platelet thromboxane A2 receptors. Mihara S; Hara S; Ueda M; Ide M; Fujimoto M Eur J Pharmacol; 1989 Nov; 171(2-3):179-87. PubMed ID: 2533558 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552. Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833 [TBL] [Abstract][Full Text] [Related]
28. Comparison of vascular and platelet thromboxane A2/prostaglandin H2 receptors in the pig. Mihara S; Hara S; Ueda M; Ide M; Fujimoto M Eur J Pharmacol; 1989 Feb; 160(3):313-21. PubMed ID: 2523812 [TBL] [Abstract][Full Text] [Related]
29. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells. Matsuda K; Mathur RS; Duzic E; Halushka PV Am J Physiol; 1993 Dec; 265(6 Pt 1):E928-34. PubMed ID: 8279549 [TBL] [Abstract][Full Text] [Related]
30. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids. Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586 [TBL] [Abstract][Full Text] [Related]
31. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481 [TBL] [Abstract][Full Text] [Related]
32. Mechanism for homologous downregulation of thromboxane A2 receptors in cultured human chronic myelogenous leukemia (K562) cells. Dorn GW J Pharmacol Exp Ther; 1991 Oct; 259(1):228-34. PubMed ID: 1833525 [TBL] [Abstract][Full Text] [Related]
33. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic. Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791 [TBL] [Abstract][Full Text] [Related]
34. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes. Theis JG; Dellweg H; Perzborn E; Gross R Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312 [TBL] [Abstract][Full Text] [Related]
35. 12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets. Fonlupt P; Croset M; Lagarde M Thromb Res; 1991 Jul; 63(2):239-48. PubMed ID: 1837628 [TBL] [Abstract][Full Text] [Related]
36. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets. Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950 [TBL] [Abstract][Full Text] [Related]
37. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets. Mais DE; Kochel PJ; Saussy DL; Halushka PV Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736 [TBL] [Abstract][Full Text] [Related]
38. Purification and characterization of the human platelet TXA2/PGH2 receptor. Narumiya S; Ushikubi F; Nakajima M; Hirata M; Okuma M Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():339-46. PubMed ID: 1825566 [No Abstract] [Full Text] [Related]
39. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets. Dorn GW J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760 [TBL] [Abstract][Full Text] [Related]
40. In vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function. Dubé GP; Jakubowski JA; Brune KA; Bemis KG; Kurtz WL J Pharmacol Exp Ther; 1995 Feb; 272(2):799-807. PubMed ID: 7853197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]